Quantinno Capital Management LP Entrada Therapeutics, Inc. Transaction History
Quantinno Capital Management LP
- $22.5 Billion
- Q2 2025
A detailed history of Quantinno Capital Management LP transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 18,622 shares of TRDA stock, worth $118,435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,622Holding current value
$118,435% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TRDA
# of Institutions
106Shares Held
28.8MCall Options Held
15.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$30.9 Million0.33% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$27.9 Million67.92% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.31MShares$27.4 Million19.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.57MShares$16.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$10.8 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $200M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...